In (b)(6) 2012, i was diagnosed with stage 1a breast cancer (er+, pr-, her2-, ln 0/3, brca neg,) and had a unilateral mastectomy on my right breast.An oncotype dx test was performed on my tumors to determine if this early stage breast cancer needed chemotherapy to reduce my risk of recurrence.The result was an intermediate score of 21.At that time, the intermediate range went from 18 - 30, so i was considered in the "low range of intermediate." both my surgeon and oncologist discussed with me the pros and cons of chemo, but tended to side towards no chemo.I sought out other opinions - one oncologist said "get chemo, no question", another surgeon said "it was a toss-up as to the benefits vs the side effects." and another doctor wanted to draw a line down the middle, and say that 21 was closer to "low risk" so i didn't need chemo.I was also invited to fly down to (b)(6) for a consult (i didn't go.) my oncologist said it was my decision and that he would not specifically say "do chemo." i didn't go to medical school, so why am i making this decision? i found the results of this test to be very misleading and highly confusing.As this tent was created to determine my need for chemotherapy, no one was able to provide a clear answer with back up data.I then learned that the test was not fda cleared, and that the statistics that were quoted to me depended on taking tamoxifen for five years (that point was not clearly stated).How can a test with so many holes be on the market? this company needs to be held accountable for misleading patients!.
|